Study: Fewer prescription drugs when cannabis is legal
Two researchers have found a link between the legalization of cannabis and a drop in drug prescriptions in the United States. In the 18 American states where the plant is legal, For example, sales of anti-anxiety capsules fell by 12 %, but also by 11 % for depression and sleep disorders, 10 % for epileptic seizures, and 8 % for painkillers. Only drugs for nausea, glaucoma or multiple sclerosis remain unchanged.
«These results are important. It could save social security programs money. Also, it's a chance to reduce the harm associated with the dangerous side effects of some prescribed drugs.», says Shyam Raman, co-author of the study, in a press release.
Both scientists are young PhD students. Shyam Raman is studying at Cornell's Institute of Public Policy; Ashley Bradford is at Indiana University. Their study was published in Health Economics and reviewed by other scientists, as is customary.
Cannabis to replace opioids
To obtain these results, Raman and Bradford recovered data from various Medicaid, the social security programs specific to each American state. Their term runs from 2011 to 2019, i.e. one year before the first state legalizes cannabis. In places where the «green wave» has taken hold, scientists are observing a statistical drop in drug prescriptions.
However, the authors warn against extrapolating these results. Their work is purely statistical. They did not interview patients to find out whether they had left their capsules. for cannabis. On social networks, some Americans are reporting that they have almost stopped taking their medication. But it's difficult to extend this situation to several million people.
https://twitter.com/andymorgan76/status/1516764759290531856?s=20&t=jK2HutOaiTdm92kv-GRF0A
In any case, the study by the two young doctoral students confirms a trend. Other studies show that cannabis with a high dose of CBD can be an interesting alternative to opioids, These powerful drugs cause 50,000 deaths a year in the United States.
«Pharmaceutical drugs are generally associated with dangerous side effects or, as is the case with opioids, a risk of misuse.», write the two authors in their study.
-
Cannabis in France4 weeks ago
France Sets July as the Deadline for the Widespread Adoption of Medical Cannabis
-
Cannabis in Europe2 weeks ago
Bosnia and Herzegovina Continues to Roll Out Medical Cannabis Following Its Legalization
-
Cannabis in France2 weeks ago
France Submits the Long-Awaited Decree on the Reimbursement of Medical Cannabis to the Council of State
-
Cannabis in the U.S.2 weeks ago
The DEA Begins Hearings on the Federal Rescheduling of Cannabis
-
Cannabis in Ireland3 weeks ago
The Irish Parliament recommends decriminalizing all drugs
-
Business4 weeks ago
Sanity Group is expanding its presence in Switzerland through a distribution agreement with Astrasana
-
Cannabis in France4 weeks ago
Medical Cannabis in France: What the First Major Study Reveals About Its Actual Impact
-
Cannabis in Switzerland3 weeks ago
St. Gallen, Switzerland, Launches Its 8th Legal Cannabis Pilot Project


You must be logged in to post a comment Login